Upgrade to SI Premium - Free Trial

Soligenix, Inc. (SNGX)

0.38 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26)

Latest Headlines

Form 424B3 SOLIGENIX, INC. August 7, 2026 4:14 PM - SEC Filing Form 424B3 SOLIGENIX, INC. August 7, 2026 4:13 PM - SEC Filing Form 424B3 SOLIGENIX, INC. August 7, 2026 4:11 PM - SEC Filing Form 424B3 SOLIGENIX, INC. August 7, 2026 4:08 PM - SEC Filing Form 10-Q SOLIGENIX, INC. For: Jun 30 August 7, 2026 4:06 PM - SEC Filing Soligenix, Inc. (SNGX) Tops Q2 EPS by 8c August 7, 2026 7:47 AM - StreetInsider Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results August 7, 2026 7:30 AM - PR NewsWire Form ARS SOLIGENIX, INC. For: Dec 31 August 3, 2026 4:14 PM - SEC Filing Form DEFA14A SOLIGENIX, INC. August 3, 2026 4:09 PM - SEC Filing Form DEF 14A SOLIGENIX, INC. For: Sep 17 August 3, 2026 4:07 PM - SEC Filing Form PRER14A SOLIGENIX, INC. July 23, 2026 5:14 PM - SEC Filing Form PRE 14A SOLIGENIX, INC. For: Sep 17 July 21, 2026 4:26 PM - SEC Filing Form 8-K SOLIGENIX, INC. For: Jun 26 June 26, 2026 4:07 PM - SEC Filing Form 424B5 SOLIGENIX, INC. June 26, 2026 4:05 PM - SEC Filing From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak June 26, 2026 7:02 AM - StreetInsider Form SCHEDULE 13G SOLIGENIX, INC. Filed by: MJL Manager LLC June 25, 2026 3:28 PM - SEC Filing Form 8-K SOLIGENIX, INC. For: Jun 10 June 12, 2026 4:07 PM - SEC Filing Soligenix applies for CEPI funding to develop Bundibugyo Ebola vaccine June 8, 2026 7:31 AM - StreetInsider Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine June 8, 2026 7:30 AM - PR NewsWire Full Article List